Diabetes
Showing NaN - NaN of 73
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec
- insulin glargine
-
Bay Minette, Alabama
- +186 more
Dec 16, 2016
Diabetes, Diabetes, Type 2 Trial in Canada, Puerto Rico, United States (insulin detemir, insulin glargine, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin detemir
- +2 more
-
Birmingham, Alabama
- +77 more
Jan 30, 2017
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin detemir, insulin NPH)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin detemir
- insulin NPH
-
Birmingham, Alabama
- +95 more
Jan 27, 2017
Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin detemir, insulin NPH, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- insulin detemir
- +2 more
-
Bree, Belgium
- +41 more
Jan 26, 2017
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- placebo
-
Cypress, California
- +19 more
Jan 25, 2017
Diabetes, Diabetes, Type 2 Trial in United States (biphasic insulin aspart, pioglitazone, metformin)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- biphasic insulin aspart
- +2 more
-
Birmingham, Alabama
- +72 more
Jan 10, 2017
Diabetes, Diabetes, Type 2 Trial in Puerto Rico, United States (biphasic insulin aspart, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- biphasic insulin aspart
- insulin glargine
-
Birmingham, Alabama
- +72 more
Jan 10, 2017
Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in Worldwide (biphasic insulin aspart, biphasic human insulin)
Completed
- Diabetes
- +2 more
- biphasic insulin aspart
- biphasic human insulin
-
Graz, Austria
- +36 more
Jan 3, 2017
Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in Worldwide (biphasic insulin aspart 50, biphasic insulin aspart 70,
Completed
- Diabetes
- +2 more
- biphasic insulin aspart 50
- +2 more
-
Aalst, Belgium
- +76 more
Jan 3, 2017
Diabetes, Diabetes, Type 1 Trial in United States (insulin human, insulin lispro, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- insulin human
- +2 more
-
Birmingham, Alabama
- +75 more
Dec 21, 2016
Diabetes, Diabetes, Type 1 Trial in Worldwide (human insulin, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- human insulin
- insulin aspart
-
Ciudad de Buenos Aires, Argentina
- +94 more
Dec 20, 2016
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/insulin aspart, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec/insulin aspart
- insulin glargine
-
Birmingham, Alabama
- +91 more
Oct 26, 2016
Hypertension, Diabetes Trial in United States (Placebo, Azilsartan medoxomil)
Terminated
- Hypertension
- Diabetes
- Placebo
- Azilsartan medoxomil
-
Birmingham, Alabama
- +67 more
Apr 20, 2015
Diabetes, Hypertension, Insulin Resistance Trial in Birmingham (The DASH diet with weight loss, The DASH diet without weight
Completed
- Diabetes
- +2 more
- The DASH diet with weight loss
- +2 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham Nutrition Sciences Departmen
Mar 15, 2013
Diabetes Trial in Birmingham (Ramipril, Candesartan cilexetil, Allopurinol)
Completed
- Diabetes
- Ramipril
- +2 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Nov 16, 2012
Diabetes Trial in United States (Phentermine/Topiramate, Placebo)
Testing the Developmental Origins Hypothesis
Unknown status
- Diabetes
- +2 more
-
New Haven, Connecticut
- +40 more
Mar 1, 2012
Satisfaction of People With Type 2 Diabetes: A European Survey
Completed
- Diabetes
-
Antibes, France
- +301 more
Apr 26, 2010
European Study of Cardiovascular Risk
Completed
- Cardiovascular Risk Factors
- +5 more
-
Alland, Austria
- +777 more
Oct 28, 2009